Skip to main content
Premium Trial:

Request an Annual Quote

Marijn Dekkers

Marijn Dekkers has been named chairman of the board of synthetic biology firm Ginkgo Bioworks. He also will serve as a strategic advisor of the Boston-based company. Dekkers most recently served as CEO of Bayer AG, and prior to that was CEO of Thermo Fisher Scientific. He also currently serves as chairman of Unilever and is founder and chairman of Novalis LifeSciences, a boutique investment and advisory firm.

The Scan

Comfort of Home

The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity.

Keep Under Control

Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says.

Just Make It

The New York Times writes that there is increased interest in applying gene synthesis to even more applications.

Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus

In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.